- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 1, 2025 | 58.78M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $893.23M |
| Current Assets | FY 2024 · Dec 31, 2023 | $3.3B |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.59B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 58.1M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $0 |
| Capex | FY 2024 · Dec 31, 2022 | $169.34M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $31.28M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $783.11M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $1.65 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $1.70 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $112.5M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $289.81M |
| Net Income restated | FY 2024 · Dec 31, 2022 | $441.73M |
| Operating Income | FY 2024 · Dec 31, 2022 | $166.12M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $844.65M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $2.27B |
| Revenue | FY 2024 · Dec 31, 2022 | $3.11B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $1.31B |